Diagnostic value of the acid-labile subunit in acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 1091-1098

  Arosio, M ^a   Garrone, S ^b   Bruzzi, P ^b   Faglia, G ^a   Minuto, F ^b   Barreca, A ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LABILE SUBUNIT; GROWTH HORMONE; PROTEIN SUBUNIT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GROWTH HORMONE RELEASE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PRIORITY JOURNAL;

ACROMEGALY; ADENOMA; ADULT; AGING; CARRIER PROTEINS; FEMALE; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 0035052459     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.1091     Document Type: Article

References (42)

1. Evalation of acromegaly by radioimmunoassay of somto-medin-C
2. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly
3. The somatomedin C binding protein: Evidence for a heterologous subunit structure
4. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex
5. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum
6. Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I
7. Biological and immunological properties of insulin-like growth factors (IGF) I and II
8. Serum somatomedin binding proteins: Physiologic significance and interference in radioligand assay
9. 18 Sep-Pak separation
10. Assays of insulin-like growth factors and their binding proteins:practicalities and pitfalls
11. IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly
12. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults
13. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers
14. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency
15. Serum acid-labile subunit in adult growth hormone deficiency and acromegaly
16. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
17. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex
18. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver
19. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns
20. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro
21. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients
22. Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit (ALS) of the 150kDa complex by rat hepatocytes in primary culture
23. Editorial: The binding protein's binding protein: Clinical applications of acid-labile subunit (ALS) measurement
24. Circulating levels and molecular distribution of the acid-labile (a) subunit of the high molecular weight insulin-like growth factor-binding protein complex
25. Acid-labile subunit of human insulin-like growth factor binding protein complex: Measurement, molecular and clinical evaluation
26. Criteria for cure of acromegly: A consensus statement
27. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly
28. Inhibition of access of bound somatomedin to membrane receptor and immunoglobin sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acidethanol extracted serum
29. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects
30. Relationship between growth hormone and somatomedin-C levels in untreated acromegaly, after surgery and radiotherapy and during medical therapy with sandostatin (SMS 201-995)
31. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: Hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency
32. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: Serum levels and hepatic messenger ribonucleic acid responses in humans
33. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and increases in acromegalic patients
34. Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and IGF-I/IGFBP-3 ratio measurements and their relationship with an Index of clinical activity in the management of patients with acromegaly
35. A comparison of different methods for diagnosing acromegaly
36. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly
37. Insulin-like growth factor binding protein-1: Recent findings and new directions
38. Physiological role of the insulin-like growth factor binding proterns
39. Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly
40. Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy
41. Clinical studies of IGFBP-2 by radioimmunoassay